Deciphera Pharmaceuticals Llc Stock Z Score
DCPHDelisted Stock | USD 13.32 0.36 2.63% |
Deciphera |
Deciphera Pharmaceuticals LLC Company Z Score Analysis
Deciphera Pharmaceuticals' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAccording to the company's disclosures, Deciphera Pharmaceuticals LLC has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and about the same as Health Care (which currently averages 0.0) industry. The z score for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
All Next | Launch Module |
Deciphera Fundamentals
Return On Equity | -0.5 | |||
Return On Asset | -0.27 | |||
Profit Margin | (1.09) % | |||
Operating Margin | (1.09) % | |||
Current Valuation | 1.97 B | |||
Shares Outstanding | 86.48 M | |||
Shares Owned By Insiders | 28.48 % | |||
Shares Owned By Institutions | 72.03 % | |||
Number Of Shares Shorted | 3.92 M | |||
Price To Earning | (6.78) X | |||
Price To Book | 7.00 X | |||
Price To Sales | 12.65 X | |||
Revenue | 163.36 M | |||
Gross Profit | (62.55 M) | |||
EBITDA | (210.96 M) | |||
Net Income | (194.94 M) | |||
Cash And Equivalents | 383.85 M | |||
Cash Per Share | 5.74 X | |||
Total Debt | 25.88 M | |||
Debt To Equity | 0.07 % | |||
Current Ratio | 6.02 X | |||
Book Value Per Share | 3.85 X | |||
Cash Flow From Operations | (146.7 M) | |||
Short Ratio | 1.05 X | |||
Earnings Per Share | (2.21) X | |||
Price To Earnings To Growth | (0.32) X | |||
Target Price | 27.52 | |||
Number Of Employees | 355 | |||
Beta | 0.18 | |||
Market Capitalization | 2.21 B | |||
Total Asset | 473.57 M | |||
Retained Earnings | (1.43 B) | |||
Working Capital | 280.82 M | |||
Current Asset | 70.55 M | |||
Current Liabilities | 5.98 M | |||
Net Asset | 473.57 M |
About Deciphera Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Deciphera Pharmaceuticals LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deciphera Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deciphera Pharmaceuticals LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Deciphera Stock
If you are still planning to invest in Deciphera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deciphera Pharmaceuticals' history and understand the potential risks before investing.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |